Transcutaneous analyte sensor

Patent metadata

Field	Value
Publication number	US-10624539-B2
Application number	US-201916503263-A
Country	US
Kind code	B2
Filing date	Jul 3, 2019
Priority date	Mar 10, 2005
Publication date	Apr 21, 2020
Grant date	Apr 21, 2020

Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

First claim

What is claimed is:

1. A sensor system for measuring a glucose concentration in a host, the sensor system comprising:
a transcutaneous glucose sensor configured for insertion into a tissue of a host, wherein the transcutaneous glucose sensor comprises an in vivo portion and an ex vivo portion, wherein the transcutaneous glucose sensor is configured to generate a signal indicative of the glucose concentration in the host;
a mounting unit configured to be placed on a skin of the host, wherein the mounting unit is configured to receive the ex vivo portion of the transcutaneous glucose sensor, wherein the mounting unit comprises sensor electronics, wherein the sensor electronics comprises a radio frequency module; and
a receiver comprising:
a processor configured to cause interrogation of the radio frequency module and to process data received during the interrogation; and
a display configured to display an estimated glucose concentration value associated with the data received during the interrogation;

wherein the radio frequency module is configured to transmit information representative of the glucose concentration to the receiver in response to the receiver interrogating the sensor electronics;
wherein the processor in the receiver and/or a processor in the sensor electronics is configured to implement a sensor expiration period in response to the receiver interrogating the sensor electronics; and
wherein the sensor system is configured to shut down the display of the estimated glucose concentration value upon the expiration of the sensor expiration period.

2. The sensor system of claim 1 , wherein the mounting unit comprises a power source configured to power the electronics.

3. The sensor system of claim 1 , wherein the sensor electronics is operatively connected to the transcutaneous glucose sensor.

4. The sensor system of claim 1 , wherein the sensor electronics comprises an antenna configured to radiate or receive radio frequency signals.

5. The system of claim 1 , wherein the sensor electronics are in a housing, wherein the sensor electronics further comprises an antenna, wherein the antenna extends substantially around a periphery of the housing.

6. The system of claim 1 , wherein the sensor electronics are in a housing, and wherein a height of the housing is no more than 0.250 inches in its smallest dimension.

7. The sensor system of claim 1 , further comprising:
an internal power supply; and
a switch operatively connected to the internal power supply, the switch configured to switch between a first state and a second state, wherein the internal power supply is configured to be in a first power mode when the switch is in the first state and in a second power mode when the switch is in the second state, wherein the first power mode is configured to supply less power to the sensor electronics than the second power mode.

8. The system of claim 7 , wherein the internal power supply provides a bias voltage for the transcutaneous glucose sensor to generate the signal indicative of the glucose concentration.

9. The system of claim 1 , wherein the receiver is configured to power the sensor electronics via inductive coupling.

10. The system of claim 9 , wherein the inductive power is provided when the receiver is placed in proximity to the sensor electronics.

11. The system of claim 1 , wherein the sensor system is associated with a serial number.

12. The system of claim 11 , wherein the sensor electronics is configured to transmit the serial number after insertion of the transcutaneous glucose sensor in the host.

13. The system of claim 12 , wherein the serial number includes information including an intended duration of the transcutaneous glucose sensor.

14. The system of claim 1 , wherein the system is configured to transmit the sensor expiration period after the insertion.

Assignees

• Dexcom Inc

Inventors

• Brister Mark C
• Pryor Jack
• Nolting John
• Leach Jacob S
• Pestana Luis
• Quintana Nelson
• Swanson Vance
• Goode Jr Paul V
• Thrower James Patrick

Classifications

• A61B5/6848

  Needles · CPC title

• A61B5/14865

  invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title

• A61B5/14532

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61B5/150022

  for capillary blood or interstitial fluid · CPC title

• G16Z99/00

  Subject matter not provided for in other main groups of this subclass · CPC title